Primary and secondary ameloblastic carcinoma can be classified into not distinct categories but a single entity: A comparative study

Wei Liu; Qin Zhou; Chenping Zhang; Huan Shi; Tong Ji

doi:10.1016/j.oraloncology.2022.106121

Primary and secondary ameloblastic carcinoma can be classified into not distinct categories but a single entity: A comparative study

Oral Oncol. 2022 Nov:134:106121. doi: 10.1016/j.oraloncology.2022.106121. Epub 2022 Sep 12.

Authors

Wei Liu¹, Qin Zhou², Chenping Zhang³, Huan Shi⁴, Tong Ji⁵

Affiliations

¹ Department of Oral and Maxillofacial-Head and Neck Oncology, Fengcheng Hospital of Fengxian District, Shanghai Ninth People's Hospital Fengcheng Branch Hospital, Shanghai, China; Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
² College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China; Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
⁴ College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China; Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: shihuan1312@163.com.
⁵ Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China. Electronic address: jit1375@sh9hospital.org.cn.

PMID: 36088790
DOI: 10.1016/j.oraloncology.2022.106121

Abstract

Background: Ameloblastic carcinoma (AC) was categorized into primary-type and secondary-type AC by 2005 World Health Organization (WHO) classification, whereas it is reclassified as a single entity in the new WHO classification. However, large sample studies are required to further evaluate and reinforce the classification.

Materials and methods: The clinical behaviors and prognosis of primary AC (n = 25) and secondary AC (n = 24) were comparatively analyzed in a retrospective study of 49 AC patients with a mean follow-up period of 64.5 months.

Results: Differences in all the clinical parameters, including age, gender, tumor site, tumor diameter, teeth involved, maxillary sinus invasion, cranial base invasion, soft tissue invasion, treatment, metastasis, recurrence, and survival status, were not observed between primary and secondary AC groups (all P > 0.05). Cox regression analysis revealed that the association of all the parameters with patients' survival were not significantly different between the two groups, respectively. Consistently, Kaplan-Meier analysis showed that the significant differences in disease-free survival and overall survival were not also observed (P > 0.05).

Conclusion: We for the first time addressed that primary-type and secondary-type AC could be classified into not distinct categories but a single entity by a retrospective clinical study.

Keywords: Ameloblastic carcinoma; Ameloblastoma; Odontogenic tumor; Survival; WHO classification.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Ameloblastoma* / pathology
Carcinoma* / pathology
Humans
Odontogenic Tumors* / pathology
Prognosis
Retrospective Studies